Closed projects

Since its creation, the department ovo r&d has already completed many research projects. Here is the list as well as some characteristics about each of these projects.

  • Académie

  • Request for information (Accueil)

  • Discover the ovo clinic

  • Contact us

    Contact us

    clinique ovo montreal

    All services offered
    8000, boul. Décarie,
    Montreal Qc H4P 2S4

    ovo fertility
    office 100 & 200
    Business hours:
    Monday to Friday 7:30am to 4pm
    Saturday, Sunday and holidays: 8am to 2:30pm
    Call center schedule:
    Monday to Friday 7:30am to 5pm
    Saturday and Sunday: 8am to 12pm
    ovo elle
    bureau 600
    Monday to Friday 8am to 4pm
    ovo cryo
    Monday to Wed. 8am to 5pm
    Thursday 8am to 6pm
    Friday 8am to 5pm
    Saturday 9am to 3pm
    Appointments :
    Monday to Friday 9am to 3pm
    Thursday 9am to 4pm
    Saturday 9am to 2:30pm
    ovo biosurance
    office 600
    Monday to Friday 8am to 4pm
    ovo labo
    office 600
    Monday to Friday 8am to 4pm
    ovo prenatal
    office 600
    Monday to Friday 8am to 4pm
    ovo r&d
    office 600
    Monday to Friday 7:15am to 5pm

    clinique ovo rive-sud

    3141, boul. Taschereau,
    Greenfield Park Qc J4V 2H2

    ovo fertility – some services offered
    office 410
    Business hours:
    Monday to Friday 7:30am to 4pm
    Call center schedule:
    Monday to Friday 7:30am to 5pm
    Saturday and Sunday: 8am to 12pm
    ovo prenatal – some services offered
    office 420
    Monday to Friday 8 am to 4 pm
    ovo labo – some services offered
    office 420
    Monday to Friday 8am to 4pm

    clinique ovo quebec

    ovo prenatal – some services offered
    2600 Boul. Laurier, suite 295,
    Quebec Qc G1V 4T3


    Monday to Friday 8am to 4pm

    clinique ovo rive-nord

    ovo prenatal – Prenatal screening
    1000 Montée des Pionniers,
    Terrebonne QC J6V 1S8


    Monday to Thursday 9am to 3pm

    clinique Echo-medic

    Ovo prenatal – some services

    1575, boul. de l’Avenir, suite 110,
    Laval Qc H7S 2N5
    t. 1.877.664.3246
    Monday to Thursday 7:30am to 4:30pm
    Friday 7:30am to 3pm
    20865, chemin de la Côte Nord, suite 201
    Boisbriand Qc J7E 4H5
    t. 1.877.664.3246
    Monday to Thursday 8 am to 4pm
    Friday 8am to 3pm

    Soins de santé du nord

    Ovo prenatal – some services

    742 rue de la Madone
    Mont-Laurier Qc J9L 1S9
    t. 819.440.2024
    On appointment
    Montreal and South-Shore: t. 514.798.2000
    Quebec: t. 418.425.0128
    f. 514.798.2001
  • Announce your Day 1

  • Make an appointment

Basic : A randomised, placebo-controlled, double-blind, parallel groups, multinational, multicenter trial assessing the effect of Barusiban administered subcutaneously on the day of transfer on implantation and pregnancy rates in IVF/ICSI patients.Ferring18

Research projects Sponsor Number of participants
In Vitro Fertilization
G-CSF INJECTION: Effects of exogenous recombinant G-CSF results in IVF/ICSI in women with repetitive embryo implantation failure. 15
G-CSF FIV NAT: Impact of follicular and blood G-CSF on pregnancy and implantation rate during modified natural in vitro fertility cycle. 152
OVOGEN: A randomized, double-blind, trial evaluating autologous endometrial co-culture (AECC) vs conventional medium in the treatment of fertility.
450-600: Effect of a Higher than Maximum 450IU Gonadotropin Dose on Patient Outcome in an IVF Setting : A Randomized Controlled Non-Inferiority Trial. 366
Chronic Endometritis : Phase I:
Prevalence of chronic endometritis in Patients with Recurrent Miscarriages or Repeated Implantation Failures in In-Vitro Fertilization.
G-test : Validation of the procedure 68
Doppler : Perifollicular Doppler in natural cycle IVF 160
PEPI : Pilot Study in order to Examine the Ultrasound Parameters Predictive of Implantation 387
Marvelon vs Nuvaring : Effects of using NuvaRing on coordinating IVF cycles and on the level of satisfaction and stress on users: randomized public study 8
Implant : A phase 3, double-blind, randomized, placebo-controlled study to assess the safety and efficacy of a single oral administration of nolasiban to increase on-going pregnancy rate following fresh single blastocyst transfer resulting from IVF. 21
E4 Freedom : A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15mg Estetrol and 3mg Drospirenone. 10
Follicular fluid : Comparative study of non-esterified fatty acid concentrations in follicular fluid in women with and without polycystic ovarian syndrome during an in vitro fertilization protocol. 7
MYOVANT /SPIRIT 1:A study that aims to evaluate the efficacy and the safety of a new experimental drug called relugolix in the treatment of endometriosis associated pain. 3
Esparios :Étude multicentrique de phase IIb à répartition aléatoire, en groupes parallèles, à double insu et à double placebo visant à évaluer pendant une période de traitement de 12 semaines l’efficacité et l’innocuité de différentes associations de doses d’un inhibiteur de l’aromatase et d’un progestatif contenues dans un anneau vaginal, par rapport à un placebo et à la leuproréline/l’acétate de leuprolide, chez des femmes atteintes d’endométriose symptomatique. 4
Violet petal study : A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to severe endometriosis-associated pain. 2
VIOLET PETAL STUDY EXTENTION : Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain. 1
ASTEROID 5: A randomized, parallel-group, double-blind, double-dummy, active-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids. 9
Fibromyomes utérins M12-813 : A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids. 4
LH URINAIRE : Combining urinary luteinizing hormone testing with ultrasound monitoring in intra uterine insemination cycles.
Crinone : Observational study evaluating the use of intravaginal Crinone for luteal support in intrauterine insemination with gonadotropins 40
Prenatal Screening
PlGF: Prospective study in order to evaluate the benefits of 1st trimester risk markers in detecting early onset preeclampsia and the use of Placental Growth Factor (PlGF) as a potential marker for trisomy 21 and other aneuploidies.
Stems cells
MSC : Evaluation of the isolation and proliferation potential of the mesenchymal stem cells contained in the “waste” portion of a cord blood sample. 22
FERRING LUTREPULSE OMNIPOD: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism.
AMH: Multi-Center Clinical evaluation if the Access AMH Assay to measure AMH as an aid in the prediction of poor ovarian response to controlled ovarian stimulation.
IRNPQ : Integrated Research Network in Perinatalogy of Quebec and Eastern Ontario 3
PCR digital : Screening for chromosomal abnormalities on fetal cells. 276
Projet experience couple´: Dyadic and dynamic co- construction of meaning from the experience of fertility treatments among heterosexual couples. 3
Second part of the development of a test to evaluate the receptivity and tolerance of the endometrium for the embryo : Personalized Molecular Test Based on the Receptivity of the Endometrium and the Maternal-Embryonic Cross-Talk.